https://www.selleckchem.com/pr....oducts/pf-477736.htm
e performance of OGTT in patients with this disorder. Our results demonstrate the presence of higher prevalence of IR in MS patients compared to healthy individuals, and strong association between impaired glucose metabolism and disability. Finally, it has to be emphasized that further studies are warranted to confirm our findings implicating that MS patients have significantly higher risk of impaired glucose metabolism, which could suggest the potential importance of the performance of OGTT in patients with this disorder. Previous st
إعجاب
علق
شارك
